Skip to content

Envoy Medical COCH Amortization Of Financing Costs And Discounts

Amortization Of Financing Costs And Discounts at other companies

Nabors Industries logo
Nabors IndustriesNBR
$1.77M-17.1%
PRA Group logo
PRA GroupPRAA
$2.18M+14.9%
TFX
TeleflexTFX
$1.48M+74.0%
Clear Channel Outdoor Holdings, Inc. logo
Clear Channel Outdoor Holdings, Inc.CCO
$2.46M-17.2%
MAG
MagneraMAGN
$6M+20.0%
NextNav logo
NextNavNN
$2.78M+59.6%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's amortization of financing costs and discounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's amortization of financing costs and discounts?
Envoy Medical (COCH) reported amortization of financing costs and discounts of $4K in Q4 2025.
How has Envoy Medical's amortization of financing costs and discounts changed year-over-year?
Envoy Medical's amortization of financing costs and discounts decreased by 99.0% year-over-year, from $384K to $4K.
What does amortization of financing costs and discounts mean?
The periodic expense recognized to allocate the costs of obtaining debt financing and original issue discounts over the life of the associated debt instrument. It provides insight into the effective interest cost of the company's borrowing activities beyond the stated coupon rate.